How PCD Franchise Companies have Changed the Pharma Industry 

The pharmaceutical industry is changing rapidly. Like the international market, the domestic market is also going through revolutionary changes. Ever since the Indian market opened up, the entire dynamics of the domestic market has changed dramatically. Where big pharma companies were the only presence, today we have healthy competition from small and medium industries as well.

Much of this comes from PCD franchise company. Franchises are today partnering with both big and small companies and have become a important part of the Indian pharma market. In fact, the franchises have had an important role to play in determining the market dynamics of the pharmaceutical sector that has had a multi-layered effect, from determining pricing to strategizing marketing campaigns.

Although franchises work with both big and small pharma companies, it is the smaller franchises that have created a large impact. By widening the market, they have significantly changed its entire make-up.

Breaking big pharma monopoly

Not too long ago all we had were big pharmaceutical companies. Often these were subsidiary of even bigger international firms that kept a foothold in the Indian market through these smaller offices. The big pharma companies have the money and machinery to push their brand and medicines. In many countries they completely dominate the market and its price mechanisms.

However, in India the franchises have made a significant difference. Unlike many other countries, India has a booming SME sector with an even wider net of franchises. The sheer number of franchises means that people always have an alternative to the bigger brands. This has effectively broken the monopoly of bigger pharma companies.

In fact, big pharma companies have had to seriously consider their pricing mechanism in the face of competition from Indian firms. Even in the international market, Indian firms today lead the market in terms of volume. The churning of international markets has made Indian firms one of the most dominant players in the world sector.

In India the same dynamics have come to play. Recent court judgements have further added to break the big pharma monopoly as court removed patent demand from two leading companies, opening up their competition from the generic drug producing smaller firms and their franchises.

Propping up small firms

No local economy can thrive without the entrepreneurial spirit of its own people. After the markets opened up on liberalizations, the entrepreneurial Indian set shop and soon there were a number of firms in the small and medium sector which started the change we see today. Even these were supported by a network of franchises.

These early small and medium companies were the first to face-off against the bigger brands. PCD pharma franchise company gave them the critical support they needed by providing them with an infrastructure for growth. They gave them access to an expanding market, the means of raising revenues and the ability to increase their brand power.

The new wave comes from start-ups. These new age companies are again slowly changing the make-up of the Indian pharma sector by putting the focus on healthcare instead of ad hoc treatment. This is a long-term engagement that goes beyond the simple sale of drugs. Franchises are again playing an important role here by giving these fledging companies the valuable support they need.

Reaching remote areas

Healthcare in India was traditionally too skewed in favor of big urban areas. However, the focus of expansion is now shifting to Tier II and III cites as well as the rural sector and leading the charge is the franchises. Most firms, whether big and small, make their initial foray in these markets through their franchises. These minimizes their loss, while giving them access to a local market firm. In broader terms, this has meant the expansion of healthcare in India and its access for more and more Indians.

Bringing price parity

The SME sector may not bring out life changing medicines too often, but they do give us an affordable access to generic drugs. Without these firms and their franchises we would only have big pharma companies setting up their price slabs — often to the detriment of the common man.

Conclusion

The PCD franchise companies have been an important part of the pharmaceutical industry in India. By providing a support structure for small and medium companies, these firms have made a significant impact on the local market dynamics.